Meningococcal Vaccine Industry Analysis: Market Size, Regional Insights, and Key Players by 2031

Meningococcal Vaccine Market Report: Unlocking Growth Potential and Addressing Challenges
United States of America – September 4, 2025

The Insight Partners presents its latest analysis, “Meningococcal Vaccine Market: An In-depth Analysis.” This publication delivers a comprehensive review of growth outlook, market segmentation, and competitive leadership within the meningococcal vaccine sector through 2031.

The report is segmented by Type (Bivalent, Quadrivalent, Others). The report further presents analysis based on the Brand (Menactra, Menveo, Bexsero, Trumenba, Nimenrix, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Key Findings and Insights

Market Size and Growth
The Meningococcal Vaccine Market is expected to register a CAGR of 6.0% from 2025 to 2031. Expanding immunization programs, rising disease awareness, and a focus on multivalent vaccine innovation drive global market growth.

Meningococcal Vaccine Market Segmentation

Type

Bivalent
Quadrivalent
Others

Brand

Menactra
Menveo
Bexsero
Trumenba
Nimenrix
Others

The List of Companies

PFIZER INC
NOVARTIS AG
SANOFI
SERUM INSTITUTE OF INDIA LTD.
GLAXOSMITHKLINE PLC
MERCK AND CO., INC.
HUALAN BIOLOGICAL ENGINEERING INC.
INCEPTA PHARMACEUTICALS LTD
WALVAX BIOTECHNOLOGY CO., LTD.
BIO-MANGUINHOS

Conclusion

The Meningococcal Vaccine Market report (2025–2031) is an essential guide for vaccine innovators, healthcare providers, and policy makers. With expanding applications, major global brands, and a strong focus on disease prevention, the sector is positioned for continued growth and impactful innovation.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.